This website uses cookies to enhance the user experience.
U

ULTIMOVACS ASA996 713 008

Research
Public limited company
Ullernchausséen 64 0379 OSLO, Norge

ULTIMOVACS ASA

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
13 years
since Mar 29, 2011
Type
Public limited company
VAT registered
Yes
Number of employees
15

Ownership

Number of shares and share classes
34,406,061
1 share class
Total number of shareholders
6389
505 companies, 5,884 persons

Financials

Annual total result 2023
-183,721,000
NOK
Total equity 2023
309,373,000
NOK
Last update: Sep 12, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Board Member-
Board Member-
ResignedAlternate Member
2.05 %
indirectly
Chairman-

Others

NameRoleShares
E
ERNST & YOUNG AS
Auditor-
A
AMESTO ACCOUNTHOUSE AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
15.1 %
indirectly
-
3.97 %
indirectly
-
3.78 %
indirectly
-
3.73 %
indirectly
Alternate Member
2.05 %
indirectly
-
1.23 %
indirectly
-
1.08 %
directly 0.08 %
indirectly 1 %
-
1 %
indirectly
Last update: Aug 27, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
G
GJELSTEN HOLDING AS
NO0010851603
6,495,866
18.88 %
C
CANICA AS
NO0010851603
2,705,957
7.86 %
W
WATRIUM AS
NO0010851603
1,780,575
5.18 %
NO0010851603
1,519,263
4.42 %
L
LANGØYA INVEST AS
NO0010851603
1,396,006
4.06 %
I
INVEN2 AS
NO0010851603
1,372,163
3.99 %
H
HELENE SUNDT AS
NO0010851603
965,802
2.81 %
C
CGS HOLDING AS
NO0010851603
882,132
2.56 %
S
SUNDT AS
NO0010851603
803,321
2.33 %
S
STAVANGER FORVALTNING AS
NO0010851603
583,416
1.7 %
NO0010851603
563,525
1.64 %
P
PRIETA AS
NO0010851603
533,988
1.55 %
NO0010851603
414,990
1.21 %
M
MYRLID AS
NO0010851603
400,000
1.16 %
F
FOLKETRYGDFONDET
NO0010851603
343,465
1 %
NO0010851603
300,000
0.87 %
W
WIAROM AS
NO0010851603
250,000
0.73 %
NO0010851603
240,000
0.7 %
NO0010851603
233,090
0.68 %
J
JAKOB HATTELAND HOLDING AS
NO0010851603
211,110
0.61 %
NO0010851603
207,407
0.6 %
NO0010851603
200,000
0.58 %
NO0010851603
198,416
0.58 %
N
NORDNET LIVSFORSIKRING AS
NO0010851603
166,939
0.49 %
NO0010851603
161,479
0.47 %
NO0010851603
156,944
0.46 %
NO0010851603
151,354
0.44 %
S
SISA INVEST AS
NO0010851603
150,000
0.44 %
L
LØREN HOLDING AS
NO0010851603
150,000
0.44 %
B
BERNT ØSTHUS AS
NO0010851603
110,000
0.32 %
T
TOHATT AS
NO0010851603
100,000
0.29 %
K
KRISTIAN FALNES AS
NO0010851603
100,000
0.29 %
NO0010851603
93,517
0.27 %
B
BASEN KAPITAL AS
NO0010851603
91,500
0.27 %
J
JAHATT AS
NO0010851603
89,290
0.26 %
A
AEOLUS AS
NO0010851603
87,500
0.25 %
A
AMFIBIEN AS
NO0010851603
87,105
0.25 %
NO0010851603
86,850
0.25 %
E
EXCESSION AS
NO0010851603
85,000
0.25 %
NO0010851603
82,003
0.24 %
NO0010851603
81,260
0.24 %
NO0010851603
80,443
0.23 %
N
NORAKS AS
NO0010851603
79,567
0.23 %
NO0010851603
76,781
0.22 %
N
NAROLA INVEST AS
NO0010851603
75,000
0.22 %
A
ANNEMVAX AS
NO0010851603
74,070
0.22 %
E
EIKR AS
NO0010851603
74,070
0.22 %
NO0010851603
72,000
0.21 %
NO0010851603
71,575
0.21 %
NO0010851603
68,239
0.2 %
S
SJÆKERHATTEN AS
NO0010851603
65,000
0.19 %
NO0010851603
64,629
0.19 %
D
DALØY AS
NO0010851603
63,219
0.18 %
NO0010851603
62,200
0.18 %
NO0010851603
61,319
0.18 %
B
BLEKE INVEST AS
NO0010851603
60,000
0.17 %
B
BENT ERIKSEN AS
NO0010851603
58,500
0.17 %
A
ANTIMA AS
NO0010851603
57,752
0.17 %
S
SNØTIND AS
NO0010851603
57,200
0.17 %
NO0010851603
54,896
0.16 %
NO0010851603
52,879
0.15 %
NO0010851603
52,670
0.15 %
NO0010851603
52,000
0.15 %
J
NO0010851603
50,250
0.15 %
F
FORENEDE FORVALTNING AS
NO0010851603
50,007
0.15 %
K
KARTEN AS
NO0010851603
50,000
0.15 %
T
TINBUEN AS
NO0010851603
50,000
0.15 %
R
RAVI INVESTERING AS
NO0010851603
50,000
0.15 %
K
KIGM HOLDING AS
NO0010851603
50,000
0.15 %
NO0010851603
50,000
0.15 %
NO0010851603
48,086
0.14 %
NO0010851603
47,000
0.14 %
J
JANDERSEN KAPITAL AS
NO0010851603
45,000
0.13 %
NO0010851603
42,960
0.12 %
N
NUNATAK INVEST AS
NO0010851603
42,218
0.12 %
S
SIVCO HOLDING AS
NO0010851603
41,883
0.12 %
P
PART INVEST AS
NO0010851603
40,000
0.12 %
NO0010851603
40,000
0.12 %
I
INTRON AS
NO0010851603
36,501
0.11 %
NO0010851603
36,000
0.1 %
K
KRETS HOLDING AS
NO0010851603
35,000
0.1 %
G
GRAFO AS
NO0010851603
34,250
0.1 %
NO0010851603
33,780
0.1 %
P
PALS EIENDOM AS
NO0010851603
32,900
0.1 %
NO0010851603
31,128
0.09 %
F
FIREH AS
NO0010851603
30,900
0.09 %
NO0010851603
30,260
0.09 %
A
AP HOLDING AS
NO0010851603
30,085
0.09 %
S
SPARLI AS
NO0010851603
30,000
0.09 %
NO0010851603
30,000
0.09 %
Z
ZOLEN & MÅNEN AS
NO0010851603
30,000
0.09 %
NO0010851603
29,340
0.09 %
NO0010851603
28,790
0.08 %
NO0010851603
28,674
0.08 %
M
MJØSCONSULT AS
NO0010851603
28,598
0.08 %
H
H5 VEKST AS
NO0010851603
28,334
0.08 %
NO0010851603
28,000
0.08 %
M
MORK HOLDING AS
NO0010851603
27,500
0.08 %
NO0010851603
27,500
0.08 %
H
HØSE AS
NO0010851603
26,110
0.08 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
0
0
0
Annual Total Result
-183,721,000
-161,126,000
-151,149,000
Total assets
362,373,000
526,748,000
667,008,000
Total liabilities
53,000,000
45,707,000
48,414,000
Total equity
309,373,000
481,041,000
618,594,000

P&L

Year202320222021
Total operating income
0
0
0
Total operating costs
210,152,000
176,962,000
150,264,000
Operating result
-210,152,000
-176,962,000
-150,264,000
Financial income/costs
26,431,000
15,836,000
-885,000
Profit before tax
-183,721,000
-161,126,000
-151,149,000
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-183,721,000
-161,126,000
-151,149,000

Balance overview

Year202320222021
Total fixed assets
94,217,000
96,960,000
86,214,000
Total current assets
268,156,000
429,788,000
580,794,000
Total assets
362,373,000
526,748,000
667,008,000
Short term debt
51,114,000
41,994,000
47,957,000
Long term debt
1,886,000
3,713,000
457,000
Total liabilities
53,000,000
45,707,000
48,414,000
Contributed capital
1,080,048,000
1,079,748,000
1,074,264,000
Retained earnings
-770,675,000
-598,707,000
-455,670,000
Total equity
309,373,000
481,041,000
618,594,000
Total equity and liabilities
362,373,000
526,748,000
667,008,000

Classification

Category
Type of organization
Public limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology